Research Disclaimer & Terms
Please review the following disclaimers and terms governing the use of CUE research compounds before placing an order.
Research Use Only
These products are sold strictly for research, laboratory, and educational purposes only. They are not intended for human consumption and have not been evaluated or approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease.
FDA Disclaimer
None of the products offered by CUE are FDA-approved. GLP-R is an investigational Phase 3 triple-agonist compound and is not approved for any indication.
Several compounds in our catalog are classified by the FDA as substances with safety concerns for compounding. Tesamorelin is FDA-approved only for HIV-associated lipodystrophy and is not represented here for any clinical indication. Injectable NAD+ is an unapproved drug.
No Medical Advice
Nothing on this site constitutes medical advice. No physician-patient or provider-client relationship is established through the use of this site or the purchase of any product.
Consult a Physician
Consult a qualified, licensed healthcare provider before using any research compound.
Assumption of Risk & Limitation of Liability
The purchaser assumes all risk and liability associated with the use, handling, and storage of any product purchased from CUE. The purchaser agrees to indemnify and hold harmless CUE from any claims arising from such use, handling, or storage.
Regulatory Status
The regulatory status described here reflects the state of the law as of March 2026. The buyer is solely responsible for verifying the current legal status of any compound in their own jurisdiction before purchase.